Market Overview:
Brain Aneurysm is an abnormal dilation of arteries in the brain which finally results in the weakening of inner muscular layer of the blood vessel wall. Over time, blood flow within the artery starts pushing the thin portion of the wall and ruptures it. The resultant bleeding due to ruptured artery in the brain is called subarachnoid hemorrhage (SAH). This kind of hemorrhage may lead to coma, stroke, and/or death. There are number of factors that contribute to the occurrence of brain aneurysms, such as cigarette smoking, injury or trauma, blood infections, and many others. Individuals harboring a brain aneurysm can be diagnosed by various techniques, such as Computed Tomography (CT) scan, Computed Tomography Angiogram (CTA) scan, Magnetic Resonance Angiography (MRA), cerebral angiogram, and many others.
The global Brain Aneurysm Treatment Market Size is expected to grow at a compound annual rate of 5.4% during the forecast period between 2017 and 2023.
Market Research Future (MRFR) asserts in its report that the global market is influenced by various key factors. This includes, the increasing and widespread prevalence of brain aneurysms, rising occurrence of high blood pressure, rapid advancements in surgical techniques, and increasing funding by the government and related bodies in the healthcare sector. Also, the presence of brain aneurysm in the family is another key driver of the market.
Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/4561
Market Research Future (MRFR) asserts in its report that the global market is influenced by various key factors. This includes, the increasing and widespread prevalence of brain aneurysms, rising occurrence of high blood pressure, rapid advancements in surgical techniques, and increasing funding by the government and related bodies in the healthcare sector. Also, the presence of brain aneurysm in the family is another key driver of the market.
Competitive Landscape:
- Sophysa Ltd
- Codman & Shurtleff
- Medtronic Plc
- Orsan Medical Technologies
- Head Sense Medical
- InfraScan
- MicroPort Scientific Corporation
- Raumedic AG
- HaiWeiKang
- Johnson & Johnson
- Spiegelberg GmbH
Market Segmentation:
- The brain aneurysm treatment market segmentation is based in terms of condition, type, and end-user.
- By type, the market divides into medication and surgery.
- The surgery segment narrows down further into endovascular coiling, surgical clipping, flow diverter, and others. The flow diverter segment breaks down into silk flow diverter (SILK), pipeline embolization device, and surpass flow diverter (SURPASS).
- The medication segment comprises calcium channel blockers, anti-seizure medications, antacids, antiemetics, analgesics, antihypertensives, stool softeners, and others.
- By end-user, the market includes clinics, hospital, and others.
- By condition, the market divides into ruptured and unruptured aneurysm.
Regional Analysis:
The global brain aneurysm treatment market is geographically segmented into major regions like Asia Pacific, Europe, the Americas, and the Middle East & Africa.
The Americas hold the dominant share of the global aneurysm treatment market and is expected to grow significantly in the forthcoming years. The growth of the region is attributed to the increasing prevalence of brain aneurysm.
The European region holds the second largest share of the market for brain aneurysm. The region’s growth is proliferated by the support provided by the government for research and development and for the improvement of reimbursement policies in healthcare. Also, cerebrovascular conditions are also seemingly prevalent in this region, which is also aiding the growth herein.
The Asia Pacific region is positioned as one of the key players in the global brain aneurysm treatment landscape. It is expected to hold the potential to be the fastest growing region among the mentioned names. The surging growth and expansion of the region can be owed to the massive patient population and the ameliorating healthcare technology.
The Middle East & Africa regions holds the least share in the brain aneurysm treatment market owing to the lack of proper availability of medical facilities. However, the decent growth market in this region is driven by some of the most advancing countries in the Middle East, including Saudi Arabia, the UAE, and Kuwait. While, the African region is expected to garner moderate growth rate.
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
Market HighlightsBrain Aneurysm is an abnormal dilation of arteries in the brain which finally results in the weakening of inner muscular layer of the blood vessel wall.
The resultant bleeding due to ruptured artery in the brain is called subarachnoid hemorrhage (SAH).
Individuals harboring a brain aneurysm can be diagnosed by various techniques, such as Computed Tomography (CT) scan, Computed Tomography Angiogram (CTA) scan, Magnetic Resonance Angiography (MRA), cerebral angiogram, and many others.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/4561A number of factors such as, increasing prevalence of brain aneurysms, advancement in surgical techniques, rising occurrence of high blood pressure, and increasing healthcare funding by government bodies are propelling the growth of brain aneurysm treatment market.
According to the Brain Aneurysm Foundation, occurrence of familial aneurysms among subarachnoid hemorrhage patients is 6% to 20%.
Despite these drivers, there are some issues associated with brain aneurysm treatment market.Regional AnalysisThe Americas dominates the brain aneurysm treatment market owing to the increasing prevalence of brain aneurysm.
According to the 2017 study published in Surg Neurol Int., it is found that more than 3% population of the United States i.e.
Brain aneurysm is also known as cerebral aneurysm or intracranial aneurysm.
Aneurysm has the potential to rupture, which causes bleeding in the surrounding sub-arachnoid space, generally resulting in brain damage or stroke.
Key causes of brain aneurysm include heredity, aging, atherosclerosis infection, and brain injury.Read Report Overview - https://www.transparencymarketresearch.com/brain-aneurysm-treatment-market.html Ruptured brain aneurysm is a critical condition and in a few cases, it could be fatal.
It is generally diagnosed with the help of magnetic resonance angiography, cerebral angiography, or computed tomography (CT) scan.
It is mostly prevalent in adults aged 35–60 years.
On the other hand, high cost of the treatment and unrecognized symptoms of the brain aneurysm are considered to be major restraining factors for the market.Based on treatment type, the brain aneurysm treatment market has been segmented into medication and surgery.
Brain Aneurysm Treatment Market Information: By Type (Surgery (Surgical Clipping, Endovascular Coiling), Medication (Antacid, Stool Softener)), Condition (Unruptured Aneurysm, Ruptured Aneurysm), End User (Hospitals, Clinics) - Global Forecast till 2027Market HighlightsBrain Aneurysm is an abnormal dilation of arteries in the brain which finally results in the weakening of inner muscular layer of the blood vessel wall.
The resultant bleeding due to ruptured artery in the brain is called subarachnoid hemorrhage (SAH).
Individuals harboring a brain aneurysm can be diagnosed by various techniques, such as Computed Tomography (CT) scan, Computed Tomography Angiogram (CTA) scan, Magnetic Resonance Angiography (MRA), cerebral angiogram, and many others.A number of factors such as, increasing prevalence of brain aneurysms, advancement in surgical techniques, rising occurrence of high blood pressure, and increasing healthcare funding by government bodies are propelling the growth of brain aneurysm treatment market.
High cost of management for aneurysmal subarachnoid hemorrhage, and unknown symptoms of unruptured brain aneurysm may hinder the growth of market to an extent.
Brain Aneurysm Foundation states that Brain aneurysms are mostly prevalent at the age of 35 – 60 years whereas aneurysmal hemorrhagic stroke is more common in people aged 50 years.It is estimated that brain aneurysm treatment market is expected to grow at a CAGR 5.4% during the forecast period of 2017-2023.
According to the 2017 study published in Surg Neurol Int., it is found that more than 3% population of the United States i.e.
Brain Aneurysm Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Brain Aneurysm industry with a focus on the Chinese market.
The report provides key statistics on the market status of the Brain Aneurysm manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Brain Aneurysm market covering all important parameters.The key points of the report:The report provides a basic overview of the industry including its definition, applications and manufacturing technology.The report explores the international and Chinese major industry players in detail.
In this part, the report presents the company profile, product specifications, capacity, production value, and 2014-2019 market shares for each company.Through the statistical analysis, the report depicts the global and Chinese total market of Brain Aneurysm industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.The report then estimates 2019-2024 market development trends of Brain Aneurysm industry.
Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.The report makes some important proposals for a new project of Brain Aneurysm Industry before evaluating its feasibility.Key questions addressed by the reportWhere will all these developments take Brain Aneurysm in the mid- to long-term?What are the upcoming technological trends in the Brain Aneurysm market?What are the opportunities for various players that exist at present and those that are planning to enter at different stages of the value chain?How growth strategies implemented by key players will impact the growth rate of the Brain Aneurysm market, and who will have the undue advantage?What are the current adoption trends of the Brain Aneurysm market?Report Sample includes:- Table of Contents- List of Tables & Figures- Charts- Research MethodologyGet FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-brain-aneurysm-2019-2024-153There are 3 key segments covered in this report: competitor segment, product type segment, end use/application segment.For competitor segment, the report includes global key players of Brain Aneurysm as well as some small players.
At least 14 companies are included: Medtronic Codman & Shurtleff Raumedic Vittamed Sophysa MicroPort ScientificThe information for each competitor includes: Company Profile Main Business Information SWOT Analysis Sales, Revenue, Price and Gross Margin Market ShareFor product type segment, this report listed main product type of Brain Aneurysm market in gloabal and china.
Surgical clipping Endovascular coiling Flow diverter OtherFor end use/application segment, this report focuses on the status and outlook for key applications.
